↓ Skip to main content

Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients

Overview of attention for article published in Frontiers in immunology, December 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients
Published in
Frontiers in immunology, December 2022
DOI 10.3389/fimmu.2022.1096881
Pubmed ID
Authors

Ibrahim Tawhari, Patrick Hallak, Sofia Bin, Fatmah Yamani, Maria Safar-Boueri, Aazib Irshad, Joseph Leventhal, Mohammed Javeed Ansari, Paolo Cravedi, Lorenzo Gallon

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 13%
Other 2 13%
Student > Bachelor 1 7%
Professor 1 7%
Researcher 1 7%
Other 1 7%
Unknown 7 47%
Readers by discipline Count As %
Unspecified 3 20%
Medicine and Dentistry 2 13%
Immunology and Microbiology 1 7%
Business, Management and Accounting 1 7%
Engineering 1 7%
Other 1 7%
Unknown 6 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 January 2023.
All research outputs
#16,063,069
of 25,392,582 outputs
Outputs from Frontiers in immunology
#16,734
of 31,549 outputs
Outputs of similar age
#233,482
of 478,271 outputs
Outputs of similar age from Frontiers in immunology
#837
of 1,671 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 31,549 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 478,271 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,671 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.